C-reactive protein modifies the association of plasma leptin with coronary calcium in asymptomatic overweight individuals

Obesity

Volumn 20, Issue 4, 2012, Pages 856-861

  Martin, Seth S ^a,b   Qasim, Atif N ^a   Rader, Dan J ^a   Reilly, Muredach P ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; LEPTIN;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; COMMUNITY; CORONARY ARTERY CALCIUM; CROSS-SECTIONAL STUDY; FEMALE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PATHOGENESIS; WAIST CIRCUMFERENCE;

EID: 85027934396     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.164     Document Type: Article

References (43)

1. Ogden CL, Carroll MD, Curtin LR et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
2. Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol 2008;52:1201-1210.
3. Singh P, Hoffmann M, Wolk R, Shamsuzzaman AS, Somers VK. Leptin induces C-reactive protein expression in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2007;27:e302-e307. (Pubitemid 47312298)
4. De Rosa S, Cirillo P, Pacileo M et al. Leptin stimulated C-reactive protein production by human coronary artery endothelial cells. J Vasc Res 2009;46:609-617.
5. Chen K, Li F, Li J et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat Med 2006;12:425-432.
6. Procopio C, Andreozzi F, Laratta E et al. Leptin-stimulated endothelial nitric-oxide synthase via an adenosine 5'-monophosphate-activated protein kinase/Akt signaling pathway is attenuated by interaction with C-reactive protein. Endocrinology 2009;150:3584-3593.
7. Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F et al. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med 2008;5:418-425. (Pubitemid 351935576)
8. Reilly MP, Iqbal N, Schutta M et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab 2004;89:3872-3878. (Pubitemid 39071487)
9. Qasim A, Mehta NN, Tadesse MG et al. Adipokines, insulin resistance, and coronary artery calcification. J Am Coll Cardiol 2008;52:231-236. (Pubitemid 351915780)
10. Reilly MP, Wolfe ML, Localio AR, Rader DJ; Study of Inherited Risk of Coronary Atherosclerosis. C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851-1856. (Pubitemid 37254874)
11. Qasim AN, Budharaju V, Mehta NN et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol (Oxf) 2011;74:44-50.
12. Wilson PW, D'Agostino RB, Levy D et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-1847. (Pubitemid 28213628)
13. Grundy SM, Cleeman JI, Daniels SR et al.; American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-2752. (Pubitemid 41532612)
14. Agatston AS, Janowitz WR, Hildner FJ et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-832. (Pubitemid 20101575)
15. Reilly MP, Wolfe ML, Localio AR, Rader DJ. Coronary artery calcification and cardiovascular risk factors: impact of the analytic approach. Atherosclerosis 2004;173:69-78. (Pubitemid 38224197)
16. Ridker PM, Danielson E, Fonseca FA et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
17. Pearson TA, Mensah GA, Alexander RW et al.; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511. (Pubitemid 36158056)
18. He Y. Missing data analysis using multiple imputation: getting to the heart of the matter. Circ Cardiovasc Qual Outcomes 2010;3:98-105.
19. Beltowski J. Leptin and atherosclerosis. Atherosclerosis 2006;189:47-60. (Pubitemid 44441296)
20. Parhami F, Tintut Y, Ballard A, Fogelman AM, Demer LL. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001;88:954-960. (Pubitemid 32441475)
21. Kang SM, Kwon HM, Hong BK et al. Expression of leptin receptor (Ob-R) in human atherosclerotic lesions: potential role in intimal neovascularization. Yonsei Med J 2000;41:68-75.
22. Zacho J, Tybjaerg-Hansen A, Jensen JS et al. Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med 2008;359:1897-1908.
23. Nordestgaard BG. Does elevated C-reactive protein cause human atherothrombosis? Novel insights from genetics, intervention trials, and elsewhere. Curr Opin Lipidol 2009;20:393-401.
24. Piemonti L, Calori G, Mercalli A et al. Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality. Diabetes Care 2003;26: 2883-2889. (Pubitemid 37205563)
25. Kazumi T, Kawaguchi A, Hirano T, Yoshino G. C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. Metab Clin Exp 2003;52:1113-1116. (Pubitemid 37203483)
26. Shamsuzzaman AS, Winnicki M, Wolk R et al. Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation 2004;109:2181-2185. (Pubitemid 38625394)
27. Abdullah SM, Khera A, Leonard D et al. Sex differences in the association between leptin and CRP: results from the Dallas Heart Study. Atherosclerosis 2007;195:404-410. (Pubitemid 350087950)
28. Reseland JE, Anderssen SA, Solvoll K et al. Effect of long-term changes in diet and exercise on plasma leptin concentrations. Am J Clin Nutr 2001;73:240-245. (Pubitemid 32109851)
29. Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 2004;43: 1056-1061. (Pubitemid 38352988)
30. Otaka M, Konishi N, Odashima M et al. Effect of alcohol consumption on leptin level in serum, adipose tissue, and gastric mucosa. Dig Dis Sci 2007;52:3066-3069. (Pubitemid 47512520)
31. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 2003;107:443-447. (Pubitemid 36158047)
32. Kajikawa Y, Ikeda M, Takemoto S et al. Association of circulating levels of leptin and adiponectin with metabolic syndrome and coronary heart disease in patients with various coronary risk factors. Int Heart J 2011;52:17-22.
33. O'Loughlin J, Lambert M, Karp I et al. Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine Tob Res 2008;10:525-532. (Pubitemid 351385834)
34. Mackintosh RM, Hirsch J. The effects of leptin administration in non-obese human subjects. Obes Res 2001;9:462-469. (Pubitemid 33600290)
35. Hukshorn CJ, Lindeman JH, Toet KH et al. Leptin and the proinflammatory state associated with human obesity. J Clin Endocrinol Metab 2004;89:1773-1778. (Pubitemid 38507933)
36. Lammert A, Kiess W, Bottner A, Glasow A, Kratzsch J. Soluble leptin receptor represents the main leptin binding activity in human blood. Biochem Biophys Res Commun 2001;283:982-988. (Pubitemid 32924677)
37. Zastrow O, Seidel B, Kiess W et al. The soluble leptin receptor is crucial for leptin action: evidence from clinical and experimental data. Int J Obes Relat Metab Disord 2003;27:1472-1478. (Pubitemid 38019159)
38. Zhang YY, Gottardo L, Mlynarski W et al. Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis 2007;191:121-127. (Pubitemid 46237631)
39. Ridker PM, Pare G, Parker A et al. Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 2008;82:1185-1192.
40. Mautner GC, Mautner SL, Froehlich J et al. Coronary artery calcification: assessment with electron beam CT and histomorphometric correlation. Radiology 1994;192:619-623. (Pubitemid 24266771)
41. Rumberger JA, Brundage BH, Rader DJ, Kondos G. Electron beam computed tomographic coronary calcium scanning: a review and guidelines for use in asymptomatic persons. Mayo Clin Proc 1999;74: 243-252. (Pubitemid 29135631)
42. Pletcher MJ, Tice JA, Pignone M, Browner WS. Using the coronary artery calcium score to predict coronary heart disease events: a systematic review and meta-analysis. Arch Intern Med 2004;164:1285-1292. (Pubitemid 38828878)
43. Elkeles RS, Godsland IF, Feher MD et al.; PREDICT Study Group. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. Eur Heart J 2008;29:2244-2251.